STOCK TITAN

Wells Fargo (WFC) pricing supplement limits UK retail sales for Series Y notes

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
424B2

Rhea-AI Filing Summary

Wells Fargo & Company has posted a pricing supplement relating to an effective registration statement (Registration No. 333-287868), subject to completion, dated May 13, 2026, for Medium‑Term Notes, Series Y — Senior Redeemable Fixed-to-Floating Rate Notes. The supplement supplements the August 28, 2025 prospectus and prospectus supplement and reiterates that the notes are unsecured obligations of Wells Fargo & Company, payments are subject to the Company’s credit risk, and the notes are not FDIC insured. The document includes UK distribution restrictions, replacing prior sales language with a Prohibition of Sales to United Kingdom Retail Investors and directs offers in the UK only to defined "relevant persons."

Positive

  • None.

Negative

  • None.

Insights

Supplement updates terms for a Series Y medium‑term note issuance.

The pricing supplement supplements the August 28, 2025 prospectus and describes the issuance vehicle as Senior Redeemable Fixed‑to‑Floating Rate Notes. It confirms the notes are unsecured obligations and subject to the issuer's credit risk, which is the primary investor exposure.

Cash‑flow treatment and aggregate offering sizes are not provided in the excerpt; subsequent pages or the prospectus supplement may contain pricing, coupon schedules, and distribution mechanics once finalized.

Supplement includes targeted UK distribution limitations and PRIIPs disclosure language.

The text replaces prior UK sales restrictions with a specific Prohibition of Sales to United Kingdom Retail Investors and states no UK PRIIPs key information document was prepared. It limits UK offers to defined "relevant persons" under the Financial Services and Markets Act frameworks.

Prospective UK investors will be required to represent they are "relevant persons"; the supplement preserves standard cross‑jurisdictional distribution qualifiers such as "subject to completion."

Registration Number 333-287868 cover/pricing supplement header
Pricing Supplement Date May 13, 2026 pricing supplement header (subject to completion)
Prospectus Date August 28, 2025 accompanying prospectus and prospectus supplement
Series Series Y Medium‑Term Notes designation
Security Type Senior Redeemable Fixed-to-Floating Rate Notes security description in heading
pricing supplement regulatory
"This pricing supplement relates to an effective registration statement"
A pricing supplement is a short, final document that gives the exact terms of a new securities offering—such as the price, interest rate, size and settlement date—building on the broader prospectus. Think of it as the day’s receipt that turns a general menu into the specific order; investors use it to see the concrete deal terms that determine value, yield and whether to buy.
UK PRIIPs Regulation regulatory
"no key information document required by Regulation (EU) No 1286/2014"
Senior Redeemable Fixed-to-Floating Rate Notes financial
"WELLS FARGO & COMPANY Medium-Term Notes, Series Y Senior Redeemable Fixed-to-Floating Rate Notes"
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

This pricing supplement relates to an effective registration statement under the Securities Act of 1933, but is not complete and may be changed. This pricing supplement and the accompanying prospectus supplement and prospectus are not an offer to sell these securities and are not soliciting an offer to buy these securities in any state where the offer or sale is not permitted.

 

Filed Pursuant to Rule 424(b)(2)
Registration No. 333-287868

SUBJECT TO COMPLETION, DATED MAY 13, 2026

Pricing Supplement No. 10 dated May , 2026

(to Prospectus Supplement dated August 28, 2025

and Prospectus dated August 28, 2025)

WELLS FARGO & COMPANY

Medium-Term Notes, Series Y

Senior Redeemable Fixed-to-Floating Rate Notes

You should read the more detailed description of the notes provided under “Description of Notes” in the accompanying prospectus supplement and “Description of Debt Securities” in the accompanying prospectus, as supplemented by this pricing supplement. The notes are unsecured obligations of Wells Fargo & Company (the “Company”), and all payments on the notes are subject to the credit risk of the Company. If the Company defaults on its obligations, you could lose some or all of your investment. The notes are not savings accounts, deposits or other obligations of any bank or nonbank subsidiary of the Company and are not insured by the Federal Deposit Insurance Corporation, the Deposit Insurance Fund or any other governmental agency. Certain defined terms used but not defined herein have the meanings set forth in the accompanying prospectus supplement and prospectus.

Aggregate Principal Amount

Offered:

$   

 

Trade Date:

May , 2026

 

Original Issue Date:

May , 2026 (T+5)

 

Stated Maturity Date:

May  , 2032; on the stated maturity date, the holders of the notes will be entitled to receive a cash payment in U.S. dollars equal to 100% of the principal amount of the notes plus any accrued and unpaid interest.

 

Optional Redemption:

At our option, we may redeem the notes (i) in whole, but not in part, on May  , 2031 (the “First Par Call Date”) or (ii) in whole at any time or in part from time to time, on or after April , 2032, in each case at a redemption price equal to 100% of the principal amount of the notes being redeemed plus accrued and unpaid interest thereon to, but excluding, the date of such redemption.

 

 

At our option, we may also redeem the notes, in whole at any time or in part from time to time, on any day included in the Make-Whole Redemption Period (as defined below), at a redemption price calculated as described under “Description of Debt Securities—Redemption and Repayment—Optional Make-Whole Redemption of Debt Securities.”

 

 

As used in connection with the notes:

 

 

The “Make-Whole Redemption Period” is the period commencing on, and including, May , 2027 and ending on, and including, May , 2031.

 


 

The “Make-Whole Spread” is   %.

 

 

Any redemption may be subject to prior regulatory approval and will be effected pursuant to the procedures described under “Description of Debt Securities—Redemption and Repayment—Optional Redemption By Us” and “—Redemption and Repayment—Optional Make-Whole Redemption of Debt Securities”, as applicable, in the accompanying prospectus.

 

Price to Public (Issue Price):

  %, plus accrued interest, if any, from May , 2026

Agent Discount

(Gross Spread):

  %

All-in Price (Net of

Agent Discount):

  %, plus accrued interest, if any, from May , 2026

 

Net Proceeds:

$   

 

Interest Rate:

The notes will bear interest at a fixed rate from May , 2026 to, but excluding, May  , 2031 (the “Fixed Rate Period”) and, if not previously redeemed, at a floating rate from, and including, May  , 2031 to, but excluding, maturity (the “Floating Rate Period”).

 

 

Fixed Rate Terms

 

Fixed Rate Period:

See “Description of Debt Securities—Interest and Principal Payments” and “—Fixed Rate Debt Securities” in the accompanying prospectus for additional information.

 

Interest Rate:

  %

 

Interest Payment Dates:

Each May  and November  , commencing November , 2026 and ending May  , 2031

 

Benchmark:

UST   % due  

 

Benchmark Yield:

  %

 

Spread to Benchmark:

+  basis points

 

Re-Offer Yield:

  %

Floating Rate Terms

 

Floating Rate Period:

See “Description of Debt Securities—Interest and Principal Payments,” “—Floating Rate Debt Securities” and “—Floating Rate Debt Securities—Base Rates—Compounded SOFR Notes” in the accompanying prospectus for additional information.

 

2


Base Rate:

Compounded SOFR

 

Spread:

+  basis points

Minimum Interest Rate for

an Interest Period:

0% per annum

 

Interest Payment Dates:

Each February , May  , August  and November , commencing August , 2031, and at maturity.

 

Calculation Agent:

The Calculation Agent for the notes has not been appointed, but we will appoint a Calculation Agent prior to the commencement of the Floating Rate Period. An affiliate of ours may be appointed the Calculation Agent. Computershare Trust Company, N.A., as security registrar and paying agent for the notes, shall not be named as “our designee” or as Calculation Agent.

 

 

 

Listing:

None

 

 

   Principal Amount      

 

Agent (Sole Bookrunner):

Wells Fargo Securities, LLC           $

Agents (Joint Lead Managers):

Agents (Co-Managers):

 

 

     Total:               $

Supplemental Plan of

Distribution:

On May , 2026, we agreed to sell to the Agents, and the Agents agreed to purchase, the notes at a purchase price of   %, plus accrued interest, if any, from May , 2026. The purchase price equals the issue price of   % less a discount of   % of the principal amount of the notes.

United States Federal

Income Tax Considerations:

In the opinion of Faegre Drinker Biddle & Reath LLP, the notes should be considered variable rate debt securities that provide for stated interest at a fixed rate in addition to a qualified floating rate. See “United States Federal Income Tax Considerations—U.S. Federal Income Taxation of U.S. Holders—Debt Securities—Variable Rate Debt Securities” in the accompanying prospectus. Notwithstanding that we expect that the notes will be issued at par, under rules governing notes with a fixed rate in addition to a qualified floating rate, it is possible that the notes could be issued with OID. Whether the notes are issued with OID will be determined at the time of issue. Information regarding the determination of the amount of OID, if any, on the notes may be

 

3


 

obtained by submitting a written request to Wells Fargo Bank, National Association, Treasury Funding Desk, N9310-060, 550 South Fourth Street, Minneapolis, MN 55415-1529.

 

 

Additional tax considerations are discussed under “United States Federal Income Tax Considerations” in the accompanying prospectus.

 

CUSIP:

95000U4J9

Risk Factors

See “Risk Factors” in the accompanying prospectus for risk factors regarding the notes, including, in particular, the risk factors appearing under the heading “Risks Relating To SOFR, Compounded SOFR And A Benchmark Replacement.”

Sales Restrictions

The sales restrictions contained in the accompanying prospectus for the United Kingdom shall be replaced with the following:

Prohibition of Sales to United Kingdom Retail Investors

The notes are not intended to be offered, sold or otherwise made available to, and should not be offered, sold or otherwise made available to, any retail investor in the United Kingdom. For these purposes:

 

  (a)

the expression “retail investor” means a person who is neither:

 

  (i)

a “professional client” as defined in point (8) of Article 2(1) of Regulation (EU) No 600/2014 as it forms part of assimilated law in the United Kingdom by virtue of the European Union (Withdrawal) Act 2018 (as amended, and together with any statutory instruments made in exercise of the powers conferred by such Act, the “EUWA”); nor

 

  (ii)

a “qualified investor” as defined in paragraph 15 of Schedule 1 to The Public Offers and Admissions to Trading Regulations 2024 (the “UK POATRs”); and

 

  (b)

the expression “offer” includes the communication in any form and by any means, presenting sufficient information on the terms of the offer and the notes to be offered, so as to enable an investor to decide to purchase or subscribe for those notes.

Consequently, no key information document required by Regulation (EU) No 1286/2014 as it forms part of assimilated law by virtue of the EUWA (the “UK PRIIPs Regulation”) for offering or selling packaged retail and insurance-based investment products or otherwise making them available to retail investors in the United Kingdom has been prepared, and therefore offering or selling the notes or otherwise making them available to any retail investor in the United Kingdom may be unlawful under the UK PRIIPs Regulation.

References in this section titled “Prohibition of Sales to United Kingdom Retail Investors” to United Kingdom legislation include any successor legislation to that legislation.

 

4


Notice to Prospective Investors in the United Kingdom

This pricing supplement and the accompanying prospectus supplement and prospectus (including any amendments thereto) have been prepared on the basis that any offer of notes in the United Kingdom will be made pursuant to public offers of relevant securities in the UK POATRs in circumstances not requiring a prospectus pursuant to the United Kingdom Financial Conduct Authority (“FCA”) Handbook Admission to Trading on a Regulated Market Sourcebook (“FCA PRM Sourcebook”). For the avoidance of doubt, while this document is described as a pricing supplement (and the accompanying documents as a prospectus supplement and prospectus), neither this document nor any accompanying document is a prospectus for the purposes of the UK POATRs or the FCA PRM Sourcebook.

In the United Kingdom, this pricing supplement and the accompanying prospectus supplement and prospectus (including any amendments thereto) are being distributed only to, and are directed only at, “non-retail investors” (being persons who are not “retail investors” as defined in the section above titled “Prohibition of Sales to United Kingdom Retail Investors”) who are also (i) persons having professional experience in matters relating to investments who fall within the definition of “investment professionals” in Article 19(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (as amended, the “Order”), (ii) high net worth bodies corporate, unincorporated associations and partnerships and trustees of high value trusts as described in Article 49(2)(a) to (c) of the Order, or (iii) other persons to whom they may otherwise lawfully be communicated (all such persons together being referred to as “relevant persons”). In the United Kingdom, any investment or investment activity to which this pricing supplement and the accompanying prospectus supplement and prospectus (including any amendments thereto) relates is only available to, and will be engaged in only with, relevant persons. Any person in the United Kingdom who is not a relevant person should not act or rely on this pricing supplement and the accompanying prospectus supplement and prospectus (including any amendments thereto) or any of their contents. Each person in the United Kingdom who purchases notes will be deemed to have represented and warranted that they are a relevant person.

References in this section titled “Notice to Prospective Investors in the United Kingdom” to United Kingdom legislation include any successor legislation to that legislation.

 

5

FAQ

What does the WFC pricing supplement cover?

The pricing supplement relates to Medium‑Term Notes, Series Y under Registration No. 333-287868, dated May 13, 2026, and supplements the prospectus dated August 28, 2025. It provides finalized terms when completed and filed.

Are the Series Y notes insured by the FDIC (WFC)?

No. The supplement states the notes are not savings accounts or deposits and are not insured by the FDIC, the Deposit Insurance Fund, or any governmental agency; they are unsecured obligations subject to the issuer’s credit risk.

Can UK retail investors buy WFC Series Y notes?

No. The supplement replaces UK sales language with a Prohibition of Sales to United Kingdom Retail Investors and restricts UK distribution to defined "relevant persons" only under applicable UK rules.

Does the pricing supplement state offering size or interest rates?

This excerpt does not include an aggregate principal amount or coupon figures. The supplement indicates those terms appear elsewhere in the prospectus package and will be provided when the pricing supplement is completed.

What is the investor credit exposure for these notes (WFC)?

Investors are exposed to the credit risk of Wells Fargo & Company because the notes are unsecured obligations; in a Company default, investors could lose some or all of their investment.